Sandy Beare

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Ujjal K. Mallick, Clive Harmer, B. Yap et al. · New England Journal of Medicine · 2012 · 606 citations · Full text

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan et al. · The Lancet Oncology · 2017 · 502 citations · Full text

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

Juan W. Valle, Harpreet Wasan, Andre Lopes et al. · The Lancet Oncology · 2015 · 276 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +8

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Rob Glynne‐Jones, David Sebag‐Montefiore, Helen Meadows et al. · The Lancet Oncology · 2017 · 178 citations · Full text

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

Tim Meyer, Amy A. Kirkwood, Sandy Beare et al. · British Journal of Cancer · 2013 · 145 citations · Full text